Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 26, 2017Frontiers in OncologyOpen Access

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSara V. SolderaMcGill University Health CentreNLNatasha B. LeighlPrincess Margaret Cancer Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Soldera et al. (2017) studied this question.

synapsesocial.com/papers/6a19d2e4ed753a62dff652e9https://doi.org/10.3389/fonc.2017.00050
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1D-type cyclin-dependent kinase activity in mammalian cells.1994 · 1,055 citations
  2. 2Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer2011 · 380 citations
  3. 3Efficacy and safety of dovitinib in pretreated patients with advanced squamous non‐small cell lung cancer with FGFR1 amplification: A single‐arm, phase 2 study2016 · 89 citations